David Woodhouse
Chief Executive Officer bij NGM BIOPHARMACEUTICALS, INC.
Actieve functies van David Woodhouse
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NGM BIOPHARMACEUTICALS, INC. | Director/Board Member | 01-09-2018 | - |
Chief Executive Officer | 01-09-2018 | - | |
Director of Finance/CFO | 02-03-2015 | 13-07-2020 | |
SURROZEN, INC. | Independent Dir/Board Member | 01-09-2020 | - |
Chairman | - | - | |
Director/Board Member | 01-09-2020 | - | |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Director/Board Member | 25-09-2020 | - |
Loopbaan van David Woodhouse
Eerdere bekende functies van David Woodhouse
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | 01-01-2002 | 01-01-2015 |
AMGEN INC. | Corporate Officer/Principal | - | - |
Opleiding van David Woodhouse
University of California, Santa Barbara | Undergraduate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Stanford University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 9 |
Operationeel
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 4 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
AMGEN INC. | Health Technology |
NGM BIOPHARMACEUTICALS, INC. | Health Technology |
SURROZEN, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- David Woodhouse
- Ervaring